Flightpath Biosciences (Drug Discovery) is Drug Discovery in United States that focus on developer business. Founded in 2019. They cover business area such as developer, biotechnology, new therapy, Lyme disease, novel therapeutic, narrow-spectrum, tick-bear disease, microbiome-target therapeutic, diagnostic, rare infectious disease, patient, a new form, treatment, no side effect.
2019
( 5 years old in 2024 )
Developer
-
2600 Tenth Street
Suite 435
Berkeley, CA 94710
United States
Private
developerbiotechnologynew therapyLyme diseasenovel therapeuticnarrow-spectrumtick-bear diseasemicrobiome-target therapeuticdiagnosticrare infectious diseasepatienta new formtreatmentno side effect
* We use standard office opening hours in near Flightpath Biosciences (Drug Discovery)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Flightpath Biosciences (Drug Discovery) is Drug Discovery business from United States that founded in 2019 (5 years old in 2024), Flightpath Biosciences (Drug Discovery) business is focusing on Developer.
Flightpath Biosciences (Drug Discovery) headquarter office and corporate office address is located in 2600 Tenth Street Suite 435 Berkeley, CA 94710 United States.
Flightpath Biosciences (Drug Discovery) was founded in United States.
In 2024, Flightpath Biosciences (Drug Discovery) is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Flightpath Biosciences (Drug Discovery), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
